Member Info for ShearClass

Bebeto, please can you explain the fundamentals that would justify a £60m market cap? From my pharma experience, you don’t have to have £44m revenue to justify a £60m market cap, indeed depending on the technology it’s not unusual for pharmas to trade at 10 x ev/sales, given NCYT already have £13m revenue it’s not hard to justify the current cap. And that’s before taking into account the current global spread of the virus, not unthinkable that NCYT could have sold 1m + tests by the end of the weekend IMO

Bought back in before the close as it feels like Novacyt are needed more than ever in the escalating situation, hard to believe this will open below 1.30 on Monday given the hysteria, RNS update also a distinct possibility.

@VauxhallViva, from my reading there is 8.4p in that 82p target price for BE?

Secondly, Largo Resources currently has a market cap of £330m with current year production forecast to be 12000kt, so you cannot expect BMN to reach 82p on production alone.

Vanadium prices are critical, and to me their future rise is dependent on VFRB adoption.

Right now BMN almost has the same market cap as Largo (who also have $156m cash on the balance sheet). Some of this can be justified by BMN’s having far larger reserves, but BMN has only a third of Largos current production.

In summary, without BE succeeding and V prices rising to at least $45, there is no way BMN gets to 82p based solely on increasing production.

Another all time low today I see, when the final results show a whopping adjusted loss & DC taking 500k in salary this should be closer to single figures IMO

https://www.pv-magazine-india.com/2020/02/15/the-long-read-go-big-go-with-the-flow/

If Largo continues to rise then BMN will inevitably follow, if anyone has been shorting this then the risk of continuing to hold has increased dramatically now the fundamentals have improved. Real bid now up to 20.01, there is a chance that this could fly today if enough PI’s notice that Vanadium has kicked on - it’s actually very much under the radar at present due to the lack of volatility in the share price.

Real bid is up to 19.75 - rise coming imminently. With vanadium prices finally on this rise this looks a tremendous buy at this level...

Jimbo666, why would they be reported when they are 3 x NMS?

20k bought pre market at 83p!

There is no arguing that it’s listed OTC on the Nasdaq, looks to have happened around 3rd Feb when you look at Google charts (there is no history before this). Highly likely this is connected to the FDA application.

Well done to whoever spotted this first!

Shame that BBC article didn’t reference Novacyt...

Definitely wouldn’t want to be out of this when the next RNS arrives, £1 close wouldn’t surprise me at all.

It’s available of catch up apparently if you have a sky box, was on the Ian King show at 1.30pm

I’ve looked for the video, sadly can’t find it anywhere! Shame that Primer Design didn’t post it on their twitter feed...

“might be worth reminding people of the truth.”

Doesn’t sound much like an opinion to me?

Ps. Does anyone have a direct link to the Sky interview? Can’t seem to find it.

That’s what I’m saying, if he’s worried about losing it or can’t afford it then he should absolutely take the profit, but also you shouldn’t put yourself if that position in the first place...

No aim no gain, you sound like an idiot - how is anyone supposed to tell you when the FDA decision will be? And what are you doing trading if you can’t afford to lose your investment? Sorry may be harsh but some people are just unbelievable!

You can’t value this on P/E at present, it’s got huge strategic value - could easily say £100m + if it’s the best test out there, which it appears to be!

Watch out for big delayed sells around the 5p area IMO. Clearly delayed trades yet to be shown which are responsible for this drop

Is this the beginning of Dave starting to sell down his 44m shares?